{
    "Case ID": "002236",
    "Different Crime": [
        {
            "Crime Name": "unknown",
            "Crime Type": "others",
            "patent_validity": [
                "not obvious",
                "sufficiently described",
                "utility established for claim 17"
            ],
            "relevant_statute": [
                "Patent Act s. 28.3",
                "Patent Act s. 2(Definitions)",
                "Patent Act s. 27(3)"
            ],
            "evidence_presented": [
                "expert testimonies",
                "prior art",
                "legal principles",
                "significant effort and experimentation required",
                "sound prediction of utility",
                "adequate description provided"
            ],
            "cause_of_action": [
                "invalidity allegations unjustified"
            ],
            "procedure_followed": [
                "Federal Court analyzed expert testimonies, prior art, and legal principles"
            ],
            "result_of_case": [
                "Leo Pharma's application granted",
                "Minister of Health prohibited from issuing Teva a Notice of Compliance until patent expires"
            ],
            "decision_reasoning": [
                "claims not obvious",
                "utility demonstrated or soundly predicted",
                "sufficient information provided for skilled persons"
            ]
        }
    ]
}